Inhibrx, Inc.

CIK 1739614 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Inhibrx, Inc..

Recent SEC filings

FiledFormAccession number
Nov 14, 2024SC 13G/A0001193125-24-258731
Jun 10, 202415-12G0001193125-24-158437
Jun 3, 202440000905148-24-001667
Jun 3, 2024SC 13G/A0000905148-24-001668
May 31, 202440000950170-24-067359
May 30, 202440000950142-24-001498
May 30, 202440000950142-24-001502
May 30, 2024S-8 POS0001193125-24-150400
May 30, 2024S-8 POS0001193125-24-150401
May 30, 202440000950142-24-001496
May 30, 202425-NSE0001354457-24-000361
May 30, 2024POSASR0001193125-24-150387
May 30, 20248-K0001104659-24-066650
May 30, 2024S-8 POS0001193125-24-150392
May 30, 202440000950142-24-001501
May 30, 202440000950142-24-001499
May 30, 202440000950142-24-001500
May 30, 202440000950142-24-001497
May 30, 2024S-8 POS0001193125-24-150398
May 28, 20241440001950047-24-004187
May 24, 202440001739614-24-000033
May 24, 202430000950142-24-001419
May 24, 20248-K0001104659-24-065125
May 22, 20241440001959173-24-003787
May 21, 2024DEFA14A0000950142-24-001388